pillbase.ru

IMMUNE PLUS Formula

Active substance: TESTOSTERONE, ADENOSINE TRIPHOSPHATE, BAPTISIA TINCTORIA ROOT, PODOPHYLLUM RESIN, CEANOTHUS AMERICANUS LEAF, FUCUS VESICULOSUS, SEPIA OFFICINALIS JUICE

SOLUTION/ DROPS · TESTOSTERONE 4 [hp_C]/mL, ADENOSINE TRIPHOSPHATE 5 [hp_X]/mL, BAPTISIA TINCTORIA ROOT 4 [hp_C]/mL, PODOPHYLLUM RESIN 6 [hp_X]/mL, CEANOTHUS AMERICANUS LEAF 7 [hp_C]/mL, FUCUS VESICULOSUS 4 [hp_C]/mL, SEPIA OFFICINALIS JUICE 1 [hp_Q]/mL

United StatesActive

Marketing holder: Apex Energetics Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing testosterone in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 10
  • Андрогель®
    гель для наружного применения, 16.2 мг/г, 88 г (original in Russian, GRLS)
    ЛП-№(000983)-(ГП-RU)
    Безен Хелскеа СА
  • Андрогель®
    гель для наружного применения, 10 мг/г, 5 г (original in Russian, GRLS)
    ЛП-№(012285)-(РГ-RU)
    Безен Хелскеа СА
  • Андрогель®
    гель для наружного применения, 10 мг/г, 5 г (original in Russian, GRLS)
    ЛС-000869
    Безен Хелскеа СА
  • Небидо®
    раствор для внутримышечного введения, 250 мг/мл, 4 мл (original in Russian, GRLS)
    ЛП-№(004023)-(РГ-RU)
    Общество с ограниченной ответственностью "Свикс Хэлскеа" (ООО "Свикс Хэлскеа")
  • Небидо®
    раствор для внутримышечного введения, 250 мг/мл, 4 мл (original in Russian, GRLS)
    ЛС-001028
    Байер АГ
All products in this country (10)
EU 2
  • Intrinsa
    testosterone
    EMEA/H/C/000634
    Warner Chilcott UK Ltd.
  • Livensa
    testosterone
    EMEA/H/C/000630
    Warner Chilcott  Deutschland GmbH
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-3b20-7c94-9ff0-9180de2898dd,01a120c3-5bd4-79ad-97dc-5478ece86c4d,01a120c3-65d2-7c75-a9cc-597659084b85,01a120c3-cbc9-7d4d-b8ca-03605e062630,01a120c5-a6b6-7f19-ad32-4213ea4b92cc;count=7 · valid from 2026-10-09 · verified 2026-10-09

  • United StatescontrolledSchedule: CIII

    Source: openFDA NDC · record 01a1208c-30f8-7219-b877-51c5cee6f22a,01a1208c-4cb8-74bf-b97b-9504f4201897,01a1208d-1735-716a-8c11-777521fe890e,01a1208d-216a-7e55-a582-accf44914de9,01a1208e-9c29-7af1-a03f-1883246e6fd0;count=50 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
63479-2509
Registration status
Active
Dispensing
Over the counter
Control marker
CIII
Route
SUBLINGUAL
Sources
  • product · openFDA NDC · 63479-2509 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 63479-2509 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 63479-2509 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 63479-2509 · Verified 2026-10-09 · open in source
  • ingredients.2 · openFDA NDC · 63479-2509 · Verified 2026-10-09 · open in source
  • ingredients.3 · openFDA NDC · 63479-2509 · Verified 2026-10-09 · open in source
  • ingredients.4 · openFDA NDC · 63479-2509 · Verified 2026-10-09 · open in source
  • ingredients.5 · openFDA NDC · 63479-2509 · Verified 2026-10-09 · open in source
  • ingredients.6 · openFDA NDC · 63479-2509 · Verified 2026-10-09 · open in source